Skip to main content
Top
Published in: Clinical Research in Cardiology 9/2015

01-09-2015 | Original Paper

High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea

Authors: C. A. Schaefer, L. Adam, J. Weisser-Thomas, S. Pingel, G. Vogel, U. Klarmann-Schulz, G. Nickenig, C. Pizarro, D. Skowasch

Published in: Clinical Research in Cardiology | Issue 9/2015

Login to get access

Abstract

Introduction

Obstructive sleep apnoea (OSA) merits increasing attention as cardiovascular risk factor. Whereas carotid and coronary artery disease have been associated with OSA, occurrence of peripheral arterial disease (PAD) in OSA remains undefined.

Methods

We screened 100 patients with suspected OSA for PAD. After polysomnography, each patient underwent standardized angiological testing including ankle-brachial index (ABI), central pulse wave velocity, pulse wave index and duplex sonography.

Results

Among total study population, PAD prevalence accounted for 88 %, of those 68 % had asymptomatic plaques and 20 % were symptomatic Fontaine ≥IIa. In confirmed OSA, prevalence raised up to 98 %. Except for smoking habits, distribution of established risk factors did not differ between OSA groups (patients without, mild, intermediate and severe OSA). Presence of plaque, Fontaine PAD stages and intermittent claudication exhibited significant gain with increasing AHI. A logistic regression model revealed that age (OR = 1.199, 95 % CI [1.066; 1.348]) and the logarithmically transformed AHI (OR = 5.426, 95 % CI [1.068; 27.567]) had the strongest influence on plaque presence. Central pulse wave velocity as marker of arterial stiffness was positively correlated with AHI.

Conclusion

OSA is associated with a high prevalence of PAD. This implies substantial disease´s under-recognition and a presumable atherogenic role of OSA in the pathogenesis of PAD. However, vasoprotective impact of OSA treatment remains to be determined.
Literature
2.
go back to reference Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177:385–390CrossRefPubMed Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177:385–390CrossRefPubMed
3.
go back to reference Okcay A, Somers VK, Caples SM (2008) Obstructive sleep apnoea and hypertension. J Clin Hypertens (Greenwich) 10:549–555CrossRef Okcay A, Somers VK, Caples SM (2008) Obstructive sleep apnoea and hypertension. J Clin Hypertens (Greenwich) 10:549–555CrossRef
4.
go back to reference Narkiewicz K, Wolf J, Lopez-Jimenez F, Somers VK (2005) Obstructive sleep apnoea and hypertension. Curr Cardiol Rep 7:435–440CrossRefPubMed Narkiewicz K, Wolf J, Lopez-Jimenez F, Somers VK (2005) Obstructive sleep apnoea and hypertension. Curr Cardiol Rep 7:435–440CrossRefPubMed
5.
go back to reference Jelic S, Padeletti M, Kawut SM et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnoea. Circulation 117:2270–2278PubMedCentralCrossRefPubMed Jelic S, Padeletti M, Kawut SM et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnoea. Circulation 117:2270–2278PubMedCentralCrossRefPubMed
6.
go back to reference Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27–32 Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27–32
7.
go back to reference Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation 105:2462–2464CrossRefPubMed Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation 105:2462–2464CrossRefPubMed
8.
go back to reference Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK (2003) Serum amyloid a in obstructive sleep apnoea. Circulation 108:1451–1454CrossRefPubMed Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK (2003) Serum amyloid a in obstructive sleep apnoea. Circulation 108:1451–1454CrossRefPubMed
9.
go back to reference Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnoea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184CrossRefPubMed Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnoea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184CrossRefPubMed
10.
11.
go back to reference Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK (2009) Obstructive sleep apnoea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 7:271–278PubMedCentralCrossRefPubMed Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK (2009) Obstructive sleep apnoea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 7:271–278PubMedCentralCrossRefPubMed
12.
go back to reference Tuleta I, Pabst S, Juergens UR, Nickenig G, Skowasch D (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis—implication for preventive and personalised treatment. EPMA J 2:39–47CrossRefPubMed Tuleta I, Pabst S, Juergens UR, Nickenig G, Skowasch D (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis—implication for preventive and personalised treatment. EPMA J 2:39–47CrossRefPubMed
13.
go back to reference Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164:1910–1913CrossRefPubMed Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164:1910–1913CrossRefPubMed
14.
go back to reference Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnoea as a risk marker in coronary artery disease. Cardiology 92:79–84CrossRefPubMed Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnoea as a risk marker in coronary artery disease. Cardiology 92:79–84CrossRefPubMed
15.
go back to reference Somers VK, White DP, Amin R et al (2008) Sleep apnoea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed Somers VK, White DP, Amin R et al (2008) Sleep apnoea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed
16.
go back to reference Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnoea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112:375–383CrossRefPubMed Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnoea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112:375–383CrossRefPubMed
17.
go back to reference Altekin RE, Yanikoglu A, Karakas MS et al (2012) Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 101:403–413CrossRefPubMed Altekin RE, Yanikoglu A, Karakas MS et al (2012) Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 101:403–413CrossRefPubMed
18.
go back to reference Dimitradis Z, Wiemer M, Scholtz W et al (2013) Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis. Clin Res Cardiol 102:895–903CrossRef Dimitradis Z, Wiemer M, Scholtz W et al (2013) Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis. Clin Res Cardiol 102:895–903CrossRef
19.
go back to reference Nakamura S, Asai K, Kubota Y et al (2014) Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep disordered breathing: a meta-analysis. Clin Res Cardiol 103:805–815CrossRef Nakamura S, Asai K, Kubota Y et al (2014) Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep disordered breathing: a meta-analysis. Clin Res Cardiol 103:805–815CrossRef
20.
go back to reference Utriainen KT, Airaksinen JK, Polo O et al (2014) Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease. Eur Respir J 41:616–620CrossRef Utriainen KT, Airaksinen JK, Polo O et al (2014) Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease. Eur Respir J 41:616–620CrossRef
21.
go back to reference Hammerstingl C, Schueler R, Wiesen M et al (2012) Effects of untreated obstructive sleep apnoea on left and right ventricular myocardial function. Int J Cardiol 155:465–469CrossRefPubMed Hammerstingl C, Schueler R, Wiesen M et al (2012) Effects of untreated obstructive sleep apnoea on left and right ventricular myocardial function. Int J Cardiol 155:465–469CrossRefPubMed
22.
go back to reference Hammerstingl C, Schueler R, Wiesen M et al (2013) Impact of untreated obstructive sleep apnoea on left- and right ventricular myocardial function and effects of CPAP therapy. PLoS One 8:e76352PubMedCentralCrossRefPubMed Hammerstingl C, Schueler R, Wiesen M et al (2013) Impact of untreated obstructive sleep apnoea on left- and right ventricular myocardial function and effects of CPAP therapy. PLoS One 8:e76352PubMedCentralCrossRefPubMed
23.
go back to reference Hein H, Raschke F, Kohler D, Mayer G, Peter JH, Ruhle KH (2001) Guideline on diagnostics and treatment of sleep-related respiratory disorders in adults. Pneumologie 55:339–342CrossRefPubMed Hein H, Raschke F, Kohler D, Mayer G, Peter JH, Ruhle KH (2001) Guideline on diagnostics and treatment of sleep-related respiratory disorders in adults. Pneumologie 55:339–342CrossRefPubMed
24.
go back to reference Epstein LJ, Kristo D, Strollo PJ Jr et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnoea in adults. J Clin Sleep Med 5:263–276PubMed Epstein LJ, Kristo D, Strollo PJ Jr et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnoea in adults. J Clin Sleep Med 5:263–276PubMed
25.
go back to reference Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619PubMedCentralPubMed Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619PubMedCentralPubMed
26.
go back to reference Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851–2906CrossRefPubMed Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851–2906CrossRefPubMed
27.
go back to reference Katakam R, Townsend RR (2006) What’s in a pulse? J Clin Hypertens (Greenwich) 8:140–141CrossRef Katakam R, Townsend RR (2006) What’s in a pulse? J Clin Hypertens (Greenwich) 8:140–141CrossRef
29.
go back to reference Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105CrossRefPubMed Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105CrossRefPubMed
30.
go back to reference Utriainen KT, Airaksinen JK, Polo O et al (2014) Sleep apnoea is associated with major cardiac events in peripheral arterial disease. Eur Respir J 43:1652–1660CrossRefPubMed Utriainen KT, Airaksinen JK, Polo O et al (2014) Sleep apnoea is associated with major cardiac events in peripheral arterial disease. Eur Respir J 43:1652–1660CrossRefPubMed
31.
go back to reference Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66CrossRefPubMed Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66CrossRefPubMed
32.
go back to reference Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091CrossRefPubMed Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091CrossRefPubMed
34.
go back to reference Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939CrossRefPubMed Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939CrossRefPubMed
35.
go back to reference El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR (2007) Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 175:1186–1191CrossRefPubMed El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR (2007) Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 175:1186–1191CrossRefPubMed
36.
go back to reference Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354–360CrossRefPubMed Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354–360CrossRefPubMed
37.
go back to reference Smith SC Jr, Milani RV, Arnett DK et al (2004) Atherosclerotic vascular disease conference: writing group II: risk factors. Circulation 109:2613–2616CrossRefPubMed Smith SC Jr, Milani RV, Arnett DK et al (2004) Atherosclerotic vascular disease conference: writing group II: risk factors. Circulation 109:2613–2616CrossRefPubMed
38.
go back to reference Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRefPubMed Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRefPubMed
39.
go back to reference Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP (2014) Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res 23(6):700–708CrossRefPubMed Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP (2014) Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res 23(6):700–708CrossRefPubMed
Metadata
Title
High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea
Authors
C. A. Schaefer
L. Adam
J. Weisser-Thomas
S. Pingel
G. Vogel
U. Klarmann-Schulz
G. Nickenig
C. Pizarro
D. Skowasch
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 9/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0834-3

Other articles of this Issue 9/2015

Clinical Research in Cardiology 9/2015 Go to the issue